Dube, ALaverty, GBalogun, Mohammed ODube, ALaverty, GBalogun, Mohammed O2026-02-092026-02-092025-032366-3987https://doi.org/10.1002/adtp.202500115http://hdl.handle.net/10204/14662We are pleased to present this special issue to highlight advances in therapeutic technologies for infectious diseases, in particular for treatment of tuberculosis (TB), HIV/AIDS and malaria. Informative reviews as well as original research articles form part of this Issue. The world's deadliest infectious diseases TB, HIV/AIDS and malaria are responsible for close to 2.5 million deaths world-wide, each year.[1] Over 90% of deaths due to malaria occur in sub-Saharan Africa, with the majority of deaths occurring in children under 5 years of age. Infectious diseases are responsible for ≈704 million disability-adjusted life-years (DALYs) and the African region bears the highest burden, with ≈314 million DALYs; while high-income countries account for only ≈31.8 million DALYs.AbstractenAdvanced therapeutic technologiesInfectious diseasesNanoparticle drug delivery systemsHost-directed therapiesHDTsLong-acting and targeted drug formulationsDrug resistance and global health burdenBookn/a